Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Aemad Aslam, MBA

President
MindPharma
Member of the Healthcare Council

Aemad Aslam, BPharm, MBA, RPh, is the President of MindPharma, a pharmacy and retail strategy consulting group. Most recently, he has consulted with a PBM, Prime Therapeutics, in Texas, a subsidiary of Blue Cross Blue Shield. He also has served as an Executive Team Leader for Pharmacy at the Target Corporation, Minnesota. Mr. Aslam has over 14 years of experience in the pharmacy retail and PBM sectors. Previously, he served as a Co-Founder of Temp360 Healthcare Solutions, a provider of software technology to healthcare staffing agencies, and as a Founder of PharmFirst, a pharmacy staffing agency. He has also served as a District Pharmacy Supervisor at the Eckerd Corporation and a Pharmacy Manager at CVS. Mr. Aslam regularly consults retail drug stores, pharmaceutical companies, and PBMs on strategies and analytics. He evaluates pricing models, valuation, and market analysis. (This is me - Update Profile)


Employment History
2006 - present President
MindPharma
2004 - 2004 Pharmacy Manager
CVS Caremark Corporation
2004 - 2007 Executive Team Leader for Pharmacy
Target Corporation
2002 - 2004 Founder, Business Strategist
Temp 360 Healthcare Solutions
1996 - 2002 District Pharmacy Supervisor
Eckerd Corporation
1995 - 1996 Pharmacy Intern
St Lukes Hospital

GLG NewsSM Analyses by Aemad Aslam, MBA(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Weak meta-analysis study and reactionary | 09-13-2007
Analysis of: Actos Bests Avandia in New Study | www.businessweek.com
Author: Aemad Aslam, MBA, President, MindPharma

    Both of Dr. Steven Nissen’s publications are meta-analysis, implying a weakness in their sampling.  In my opinion, more refined studies with larger sample sizes and standardized measurements with Actos, Avandia and placebo or other medications need to be evaluated. ...

GLG InstituteSM Seminars with Aemad Aslam, MBA(?)

 
Aemad Aslam, MBA has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Aemad Aslam, MBA









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-04T21:45:16.757